Enter a Ticker Symbol To Get Your Free Bull/Bear Rating & Ranking Report from "Stock Scientist" Mike Turner

Dividend Quote

ANTH

Anthera Pharmaceuticals Inc

Add to Scorecard

New Report from the Award-winning Analyst Who Beat the Market Over 15 Years

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.

ANTH:Anthera Pharmaceuticals Inc - Stock Quote and Dividend Data

LATEST CLOSE PRICE

$0.04

EXCHANGE

OTCBB

SECTOR

Health Care

ANTH
Anthera Pharmaceuticals Inc Dividend Information
Trailing 12 Month Dividend Yield0.00%
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years

Dividend Payment TypeNone
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend PaidNone

FREE INVESTOR BRIEFING

Collect an 8% Yield on this "Government Mandated Income Opportunity"

(For Privacy Policy visit us here)
*Note: You will not be spammed, ever. Period.
ANTH
Anthera Pharmaceuticals Inc Stock Information
Latest Close Price$0.04
52-Week Low/High$0.01 - $2.97
Percent Held by Institutions5.35%
Revenue$0
Net Income$-31,115,000
Cash Flow$-9,381,000
EPS-0.42%
Market Cap$1,177,793
PE Ratio0
PE Ratio to Industry65%
Debt-Equity Ratio0.00%
Debt-Equity to Industry1.39%
Total Return Last 12 Months-97.00%
Total Return Last 3 Years-99.88%
Total Return Last 5 Years-99.81%
Latest Trade DateDec. 13, 2018
ANTH
Anthera Pharmaceuticals Inc Dividend Payment History

No Data available for Payment History.

ANTH
Anthera Pharmaceuticals Inc Other Details

Anthera Pharmaceuticals is a biopharmaceutical company focused on advancing the development and commercialization of medicines that benefit patients with medical needs. Co. has two compounds in development, Sollpura and blisibimod. Sollpura is a non-porcine investigational Pancreatic Enzyme Replacement Therapy intended for the treatment of patients with Exocrine Pancreatic Insufficiency, often seen in patients with cystic fibrosis and other conditions. Blisibimod targets B-cell activating factor, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy.

Web Sitewww.anthera.com
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryBiotechnology
Dividend AllStar™ Ranking
Dividend Re-Investment PlanNo
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Dividend Tools

Building a successful dividend income portfolio is simple… if you have the right tools at your disposal. Here’s a sampling of Dividend Investor’s Dividend Tools, used by thousands of investors across the globe to gain a substantial edge in their portfolio strategies.

Dividend AllStar™ Ranking

Find stocks with consecutively increasing dividends:

  • = 5 years of dividend increases
  • = 10 years of dividend increases
  • = 20 years of dividend increases

Click to Learn More

Monthly Dividend Directory

Learn which investments pay out every month, including:

  • Dividend yield
  • Ex-dividend date
  • Dividend payout date… and more

Click to Learn More

Stock Screening Tools

Screen and filter thousands of dividend-paying investments with Dividend Investor’s advanced screening tools:

  • Dividend Payout Ratio
  • Consecutive Increases
  • 5-Year Total Return… and more

Click to Learn More

Try Dividend Investor PREMIUM for as low as $29

  • Dividend Allstars™ Tool
  • Proprietary Ex-dividend Calendar
  • Dividend Scorecard™ Portfolio Tracker
  • Customized Dividend Stock Screener
  • 4 FREE special reports from leading dividend experts
  • And much more...
 
Anthera Pharmaceuticals Inc Dividend Stock News and Updates

Dec. 14, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-14-2018 increased close price > 10% from $0.04 to $0.04

Read more...

Dec. 13, 2018CLOSE PRICE DECREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-13-2018 decreased close price > 10% from $0.05 to $0.04

Read more...

Dec. 11, 2018CLOSE PRICE INCREASE: Anthera Pharmaceuticals Inc (OTCBB: ANTH) on 12-11-2018 increased close price > 10% from $0.04 to $0.05

Read more...
More Anthera Pharmaceuticals Inc Dividend News
Biotechnology Dividend Stock News and Updates

Dec. 14, 2018CLOSE PRICE INCREASE: Affymax Inc (OTCBB: AFFY) on 12-14-2018 increased close price > 10% from $0.01 to $0.02

Read more...

Dec. 14, 2018CLOSE PRICE DECREASE: CTD Holdings Inc (FL) (OTCBB: CTDH) on 12-14-2018 decreased close price > 10% from $0.95 to $0.83

Read more...

Dec. 14, 2018CLOSE PRICE INCREASE: Cytori Therapeutics Inc (NASDAQ: CYTXW) on 12-14-2018 increased close price > 10% from $0.00 to $0.00

Read more...
More Biotechnology Dividend News
FREE REPORT
X
Bryan Perry Dividend Income Expert Bryan Perry

Earn 8% on this "Government Mandated Income Opportunity"

X

Search Dividend Investor